Immunoregulatory nanomedicines for the prevention and treatment of respiratory diseases

Study explores immunoregulatory nanomedicines for respiratory infections, highlighting their potential in enhancing treatment outcomes and vaccine efficacy.

Related Keywords

United States , ,Drug Administration ,Nature Reviews Bioengineering ,Middle East ,United States Food ,Respiratory ,Ntibody ,Aspergillosis ,Bacteria ,Ioengineering ,Fell ,Coronavirus ,Covid 19 ,Ytokines ,Na ,Ungi ,H1n1 ,Healthcare ,Immune System ,Immunity ,Immunotherapy ,Inflammation ,Influenza ,Lungs ,Ortality ,Nanomedicine ,Anoparticles ,Athogen ,Eptides ,Pneumonia ,Olymers ,Protein ,Respiratory Disease ,Respiratory Illness ,Cars ,Ars Cov 2 ,Evere Acute Respiratory ,Evere Acute Respiratory Syndrome ,Yndrome ,Tuberculosis ,